Predictors of response and course in patients with inflammatory bowel disease treated with biological therapy: The Danish IBD-Biobank project

被引：0
|
作者：
Zhao, M. [1 ]
Bendtsen, F. [1 ]
Petersen, A. M. [1 ,2 ]
Larsen, L. [3 ]
Jess, T. [3 ,4 ]
Dige, A. [5 ]
Hvas, C. [5 ]
Seidelin, J. [6 ]
Burisch, J. [1 ]
机构：
[1] Hvidovre Univ Hosp, Gastro Unit, Div Med, Hvidovre, Denmark
[2] Hvidovre Univ Hosp, Dept Clin Microbiol, Hvidovre, Denmark
[3] Aalborg Univ Hosp, Dept Gastroenterol & Hepatol, Aalborg, Denmark
[4] State Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark
[5] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus, Denmark
[6] Herlev Univ Hosp, Gastro Unit, Med Div, Herlev, Denmark
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P634
引用
收藏
页码：S526 / S527
页数：2
相关论文
共 50 条
  • [21] REDUCTION IN CO-THERAPY COSTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH BIOLOGICAL DRUGS
    Kostev, K.
    Kap, E. J.
    VALUE IN HEALTH, 2019, 22 : S623 - S623
  • [22] The Course of Renal Function in Patients on Mesalamine Therapy with Inflammatory Bowel Disease 2009 ACG/Centocor IBD Abstract Award
    Blonski, Wojciech
    Brensinger, Colleen
    Osterman, Mark
    Mendizabal, Manuel
    Kotlyar, David
    Lin, Ming
    Lichtenstein, Gary
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S449 - S449
  • [23] Predicting response to dose escalation in patients with inflammatory bowel disease with secondary loss of response to biological therapy
    Tambakis, G.
    Sebastian, T.
    Sun, G.
    Reynen, T.
    Van Wees, M.
    Bhoopal, A.
    Splatt, L.
    Cunningham, G.
    Shelton, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 111 - 111
  • [24] Optimizing the use of biological therapy in patients with inflammatory bowel disease
    Moss, Alan C.
    GASTROENTEROLOGY REPORT, 2015, 3 (01): : 63 - 68
  • [25] Obesity in the response to biological treatments in Inflammatory Bowel Disease patients
    Cabrerizo Mengotti, M.
    Agudo Fernandez, S.
    Castano Milla, C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1453 - I1453
  • [26] Incidence of benign infections in inflammatory bowel disease (IBD) patients treated with azathioprine (AZA)
    Seksik, Philippe
    Cosnes, Jacques
    Nion-Larmuier, Isabelle
    Gendre, Jean-Pierre
    Beaugene, Laurent
    GASTROENTEROLOGY, 2006, 130 (04) : A72 - A72
  • [27] Volatile organic metabolites to predict clinical response in patients with inflammatory bowel diseases treated with biological therapy
    Ribaldone, Davide G.
    Arezzo, Alberto
    Cardenia, Vladimiro
    Caviglia, Gian Paolo
    Abate, Maria L.
    Radice, Elisabetta
    Saracco, Giorgio M.
    Astegiano, Marco
    Morino, Mario
    MINERVA BIOTECHNOLOGY AND BIOMOLECULAR RESEARCH, 2024, 36 (04): : 195 - 202
  • [28] PPARGC1A affects inflammatory responses in photodynamic therapy (PDT)-treated inflammatory bowel disease (IBD)
    Liu, Chao
    Jiang, Yuhong
    Liu, Ganglei
    Guo, Zhushu
    Jin, Qianqian
    Long, Dongju
    Zhou, Weihan
    Qian, Ke
    Zhao, Hua
    Liu, Kuijie
    BIOCHEMICAL PHARMACOLOGY, 2022, 202
  • [29] Acute and late toxicities in patients with inflammatory bowel disease (IBD) treated with radiation therapy (RT) for abdominal and pelvic neoplasms
    Ooi, CJ
    Willett, CG
    Zeitman, A
    Goldberg, S
    Sands, BE
    Podolsky, DK
    GASTROENTEROLOGY, 1999, 116 (04) : A797 - A797
  • [30] The Clinical Course of Inflammatory Bowel Disease in Patients Receiving Cancer Therapy
    Natha, Cristina M.
    Vemulapalli, Varun
    Haque, Kazi
    Sullivan, Andrew
    Naz, Sidra
    Zhou, Emily
    Haydel, Jasmine
    Quirk, Nina
    Cruz, Carolina Colli
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S818 - S819
12345